Tag: genetic disorder
April 29, 2018
5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent
Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 1, 2018
5 Top NASDAQ Biotech Stocks: Cardiome on Top
Cardiome, Avid, XBiotech, Fennec and Compugen were last week's five top-gaining NASDAQ biotech stocks. See what moved their share prices. March 18, 2018
5 Top NASDAQ Biotech Stocks: Second Sight Medical on Top
Second Sight, Juniper, Athersys, Aptose and ArQule were last week's five top-gaining NASDAQ biotech stocks. See what moved their share...
March 15, 2018
Solid Biosciences Clinical Trial Put on Hold by FDA, Sends Share Price Tumbling
Negative findings include a decrease in platelet count, a reduction in red blood cell count and evidence of complement activation. March 4, 2018
5 Top NASDAQ Biotech Stocks: Tenax on top with a 51.94 Percent Increase
This past week the NASDAQ Biotechnology Index increased by 4.15 percent reaching 3,501.80 points in the last week—nearly equal to... February 27, 2018
The EMA Grants Accelerated Assessment for Shire’s Lanadelumab
Shire (NASDAQ: SHPG), the global biotechnology leader in rare diseases, announced today the Committee for Medicinal Products for Human Use... February 23, 2018